Capital International Investors
AZN icon

Capital International Investors’s AstraZeneca AZN Stock Holding History

Capital International Investors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.72B Buy
34,393,013
+27,132,474
+374% +$5.23B 1.58% 13
2025
Q4 		$1.34B Sell
7,260,539
-5,265,721
-42% -$924M 0.21% 93
2025
Q3 		$1.91B Sell
12,526,260
-3,176,232
-20% -$481M 0.31% 76
2025
Q2 		$2.19B Buy
15,702,492
+59,712
+0.4% +$8.37M 0.38% 64
2025
Q1 		$2.3B Sell
15,642,780
-3,110,800
-17% -$450M 0.45% 58
2024
Q4 		$2.46B Buy
18,753,580
+343,004
+2% +$48M 0.46% 56
2024
Q3 		$2.87B Buy
18,410,576
+58,717
+0.3% +$9.48M 0.55% 49
2024
Q2 		$2.86B Buy
18,351,859
+1,090,921
+6% +$164M 0.59% 46
2024
Q1 		$2.34B Sell
17,260,938
-130,443
-0.8% -$17.3M 0.47% 61
2023
Q4 		$2.34B Buy
17,391,381
+82,091
+0.5% +$10.7M 0.53% 53
2023
Q3 		$2.34B Sell
17,309,290
-1,860,593
-10% -$254M 0.59% 43
2023
Q2 		$2.74B Buy
19,169,883
+105,528
+0.6% +$15.5M 0.66% 34
2023
Q1 		$2.65B Sell
19,064,355
-1,334,819
-7% -$180M 0.68% 34
2022
Q4 		$2.77B Buy
20,399,174
+236,362
+1% +$29.6M 0.74% 31
2022
Q3 		$2.21B Buy
20,162,812
+471,312
+2% +$59.8M 0.65% 38
2022
Q2 		$2.61B Buy
19,691,500
+1,194,668
+6% +$157M 0.71% 36
2022
Q1 		$2.46B Buy
18,496,832
+802,437
+5% +$96.2M 0.56% 47
2021
Q4 		$2.06B Buy
17,694,395
+277,804
+2% +$32.7M 0.44% 59
2021
Q3 		$2.09B Buy
17,416,591
+1,391,929
+9% +$162M 0.48% 55
2021
Q2 		$1.92B Buy
16,024,662
+967,973
+6% +$106M 0.44% 62
2021
Q1 		$1.5B Buy
15,056,689
+2,062,361
+16% +$207M 0.38% 75
2020
Q4 		$1.3B Sell
12,994,328
-1,630,405
-11% -$173M 0.35% 80
2020
Q3 		$1.6B Sell
14,624,733
-294,580
-2% -$32.8M 0.5% 52
2020
Q2 		$1.58B Buy
14,919,313
+756,503
+5% +$78.1M 0.52% 47
2020
Q1 		$1.27B Buy
14,162,810
+2,687,963
+23% +$253M 0.52% 47
2019
Q4 		$1.14B Buy
11,474,847
+3,159,710
+38% +$297M 0.39% 79
2019
Q3 		$741M Buy
8,315,137
+1,750
+0% +$152K 0.28% 102
2019
Q2 		$686M Buy
8,313,387
+2,687,931
+48% +$211M 0.27% 99
2019
Q1 		$455M Buy
5,625,456
+423
+0% +$33.3K 0.2% 126
2018
Q4 		$427M Buy
5,625,033
+748,739
+15% +$58.5M 0.21% 120
2018
Q3 		$386M Buy
4,876,294
+159,708
+3% +$12.1M 0.18% 136
2018
Q2 		$331M Buy
4,716,586
+128
+0% +$9.21K 0.37% 95
2018
Q1 		$330M Sell
4,716,458
-266,747
-5% -$18.5M 0.38% 91
2017
Q4 		$346M Sell
4,983,205
-650
-0% -$43.8K 0.39% 84
2017
Q3 		$338M Sell
4,983,855
-3,298,550
-40% -$208M 0.4% 81
2017
Q2 		$565M Sell
8,282,405
-973,395
-11% -$63.6M 0.75% 40
2017
Q1 		$576M Buy
9,255,800
+271,400
+3% +$15.8M 0.78% 38
2016
Q4 		$491M Sell
8,984,400
-1,315,690
-13% -$74.7M 0.71% 43
2016
Q3 		$677M Buy
10,300,090
+63,350
+0.6% +$4.14M 0.98% 28
2016
Q2 		$618M Buy
10,236,740
+1,852,600
+22% +$108M 0.91% 33
2016
Q1 		$472M Buy
8,384,140
+253,450
+3% +$15.2M 0.72% 40
2015
Q4 		$552M Buy
8,130,690
+8,200
+0.1% +$538K 0.85% 35
2015
Q3 		$517M Buy
8,122,490
+1,659,400
+26% +$109M 0.94% 29
2015
Q2 		$412M Buy
6,463,090
+2,427,200
+60% +$166M 0.7% 40
2015
Q1 		$276M Buy
4,035,890
+2,066,500
+105% +$144M 0.5% 69
2014
Q4 		$139M Buy
1,969,390
+406,730
+26% +$29.1M 0.28% 102
2014
Q3 		$112M Buy
1,562,660
+1,660
+0.1% +$122K 0.27% 107
2014
Q2 		$116M Buy
1,561,000
+2,800
+0.2% +$202K 0.3% 105
2014
Q1 		$101M Hold
1,558,200
– – 0.27% 115
2013
Q4 		$92.5M Buy
+1,558,200
New +$84.6M 0.29% 113

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors's AZN Position: Q1 2026 in Review

Capital International Investors increased its AstraZeneca (AZN) stake by 374% in Q1 2026, buying an estimated $5.23B and bringing the position to 34,393,013 shares worth $6.72B. The position accounts for 1.58% of the portfolio, ranked #13.

Capital International Investors first reported a position in AZN in Q4 2013 and has held it in 50 quarters since. 1,381 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Capital International Investors held 34,393,013 shares of AstraZeneca worth $6.72B as of Q1 2026.
  • Capital International Investors bought 27,132,474 AstraZeneca shares in Q1 2026, an estimated $5.23B.
  • AstraZeneca made up 1.58% of Capital International Investors's portfolio in Q1 2026, its #13 holding.
  • Capital International Investors first reported a position in AstraZeneca in Q4 2013 and has held it in 50 quarters since.
  • 1,381 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Capital International Investors's 13F filing for Q1 2026, filed 13 May 2026.